The Superpowers for Good Live Pitch event on March 17 will feature four companies presenting their investment opportunities to a national television audience, with real-time audience participation shaping the broadcast. My Diabetes Health, rHEALTH, GigaWatt, and BRG Therapeutics will each deliver live pitches during the two-hour program, which includes viewer-submitted questions and live voting for the SuperCrowd Award winner.
Produced by The Super Crowd, Inc., a public benefit corporation focused on impact crowdfunding, the event aims to give mission-driven businesses a platform to reach investors while engaging the public directly in the investment process. Following the broadcast, a private investor session via Zoom will be open to anyone interested in learning more about investment opportunities, with free registration available at https://thesupercrowd.com/26q1pitch.
The format represents a shift toward more transparent, participatory investment processes. Sherwood Neiss of Crowdfund Capital Advisors noted that live questioning creates a more authentic investment environment where companies must explain their evidence, plans, and risks without excessive polish. Paul Lovejoy of Stakeholder Enterprise added that audience participation elevates conversations around traction, validation, economics, and execution, creating fairness through real-time questioning accessible to all viewers.
My Diabetes Health focuses on insurance-covered telehealth diabetes education, reporting service to 8,600 patients and average A1C improvements of 1.6 points. The company emphasizes accessibility through multi-language support and flexible scheduling to address geographic and time barriers. Léa Bouhelier-Gautreau of KingsCrowd highlighted that investors will examine how the company translates strong outcomes into a scalable operating system while maintaining effectiveness.
rHEALTH is developing a space-validated blood diagnostics platform for consumer and point-of-care use, with development connections to NASA and NIH. The company aims to deliver results in minutes rather than days, with Neiss noting that investors will seek specifics about current validation, regulatory plans, and initial customer identification. Lovejoy emphasized the importance of translating technical sophistication into practical applications, including reimbursement models and real-world constraints.
GigaWatt presents as an established distributed energy business with 19 years of operation, over $54 million in revenue since 2019, and strong customer ratings. The company connects its operational track record to broader market shifts toward electrification, solar, storage, and energy management. Bouhelier-Gautreau noted that investors will examine where defensibility lies—whether in brand, distribution, execution capability, or technology—as the company pursues expansion in a fragmented market.
BRG Therapeutics focuses on developing dual-action anticancer and antiviral therapeutics, operating in early-stage research and preclinical development. Lovejoy emphasized that therapeutic ventures require different evaluation criteria than consumer businesses, with investors seeking clear roadmaps for scientific milestones, validation plans, and partnership strategies. Bouhelier-Gautreau added that transparency about what is known versus what remains hypothetical is crucial for investor decision-making in this high-potential but demanding field.
The event will air live on Roku and Amazon Fire TV via the e360tv Network, with additional social media distribution. Viewer participation extends beyond questions to live voting for the SuperCrowd Award winner, while a separate judges' panel will select its own winner. This approach reflects the participatory nature of crowdfunding, transforming a broadcast into a live conversation between entrepreneurs and potential investors.
The implications of this format extend beyond the four presenting companies, potentially reshaping how impact investments are presented and evaluated. By allowing public questioning and participation, the event democratizes aspects of investment due diligence that are typically reserved for professional investors. For industries represented—healthcare, diagnostics, energy, and therapeutics—the format provides a transparent platform to communicate both impact potential and business fundamentals to a broad audience. This could influence how mission-driven companies approach fundraising and public communication, emphasizing clarity and evidence over marketing polish while expanding access to investment opportunities traditionally limited to accredited investors.
